Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shuji Ogino, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Shuji Ogino and Aditi Hazra.
Connection Strength

1.467
  1. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control. 2010 Mar; 21(3):331-45.
    View in: PubMed
    Score: 0.431
  2. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastroenterology. 2010 Dec; 139(6):1855-64.
    View in: PubMed
    Score: 0.111
  3. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010 May 27; 9:125.
    View in: PubMed
    Score: 0.109
  4. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn. 2010 Mar; 12(2):177-83.
    View in: PubMed
    Score: 0.107
  5. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2513-21.
    View in: PubMed
    Score: 0.104
  6. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res. 2009 Jun 01; 15(11):3663-71.
    View in: PubMed
    Score: 0.102
  7. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol. 2009 Jul; 22(7):922-32.
    View in: PubMed
    Score: 0.102
  8. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res. 2008 Dec 15; 14(24):8221-7.
    View in: PubMed
    Score: 0.099
  9. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008; 3(11):e3698.
    View in: PubMed
    Score: 0.098
  10. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis. 2007 Sep; 28(9):1985-90.
    View in: PubMed
    Score: 0.090
  11. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):816-825.
    View in: PubMed
    Score: 0.043
  12. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis. 2015 Sep; 36(9):999-1007.
    View in: PubMed
    Score: 0.039
  13. Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology. 2012 Jul; 143(1):51-4.e4.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.